2007
DOI: 10.1210/jc.2006-2295
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study

Abstract: These results suggest that 54 mg genistein plus calcium, vitamin D(3), and a healthy diet was associated with favorable effects on both glycemic control and some cardiovascular risk markers in a cohort of osteopenic, postmenopausal women.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
104
1
3

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 158 publications
(113 citation statements)
references
References 43 publications
5
104
1
3
Order By: Relevance
“…It is important to note that although participants in the present study had elevated blood pressure, mean blood pressure for this group (resting or mean 24-hour) fell within the prehypertensive range. Whereas baseline CAM concentrations appeared similar to normotensive individuals, previous reports have indicated a significant reduction in CAM with isoflavone supplementation despite baseline concentrations being much lower (Atteritano et al 2007) than those observed in our participants. Also, studies that reported significant reductions typically enrolled three to four times the number of participants in comparison to the present study.…”
Section: Discussionsupporting
confidence: 48%
See 1 more Smart Citation
“…It is important to note that although participants in the present study had elevated blood pressure, mean blood pressure for this group (resting or mean 24-hour) fell within the prehypertensive range. Whereas baseline CAM concentrations appeared similar to normotensive individuals, previous reports have indicated a significant reduction in CAM with isoflavone supplementation despite baseline concentrations being much lower (Atteritano et al 2007) than those observed in our participants. Also, studies that reported significant reductions typically enrolled three to four times the number of participants in comparison to the present study.…”
Section: Discussionsupporting
confidence: 48%
“…Atteritano et al (2007) supplemented postmenopausal women with 54 mg/day of genistein for 2 years and found sVCAM-1 and sICAM-1 to be significantly (P < 0.05) reduced compared to placebo. Colacurci et al (2005) supplemented postmenopausal women with an isoflavone tablet and also reported a significant reduction in CAM, including sVCAM-1, sICAM-1, and E-selectin.…”
Section: Cell Adhesion Molecule Expressionmentioning
confidence: 98%
“…S7B). These findings were surprising given that resveratrol and genistein are currently being tested in clinical studies as treatments for cardiovascular disease, type 2 diabetes, osteopenia, and osteoporosis (24,25); resveratrol has gained notoriety for its potential antiaging effects; and baicalein is the major constituent of a Japanese herbal remedy for chronic hepatitis (26). The genotoxicity caused by these compounds raises concerns regarding their use for such conditions and suggests a reevaluation of their safety.…”
Section: Discussionmentioning
confidence: 99%
“…서구 사회에서 전립선암, 유방암, 골다공증 및 심혈관계 질 환 등 호르몬 관련 질환의 유병률 이 콩의 섭취량이 많은 아시 아인에 비해 현저히 높은 것으로 여러 역학조사에서 밝혀짐에 따라 콩 섭취에 대한 관심이 고조되고 있다 [4,16,42]. 콩은 수 천년 동안 여러 아시아 지역에서 단백질의 중요한 급원 식품 으로 공급되어 왔고 [9,28,40] 또한 대두 단백질과 더불어 콩에 다량 함유된 isoflavone은 폐경기 증상을 완화시키고, 심혈관 질환, 골다공증 및 암의 위험을 감소시킨다는 연구들이 많이 보고되었다 [6,17,26].…”
Section: 서 론unclassified